Crossmark

HSV-1’s contribution as a vector for gene therapy

Crossref DOI link: https://doi.org/10.1038/s41587-022-01449-1

Published Online: 2022-09-09

Published Print: 2022-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Epstein, Alberto L. https://orcid.org/0000-0002-4322-1511
License Information

Text and Data Mining valid from 2022-09-01

Version of Record valid from 2022-09-01
More Information

Article History

First Online: 9 September 2022

Competing interests

: A.L.E. is a cofounder of, is CSO of, and has an equity interest in EG427.